- Home
- GLSI vs CBFV Comparison
GLSI vs CBFV Comparison
Compare GLSI & CBFV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLSI
- CBFV
- Stock Information
- Founded
- GLSI 2006
- CBFV 1901
- Country
- GLSI United States
- CBFV United States
- Employees
- GLSI N/A
- CBFV N/A
- Industry
- GLSI Biotechnology: Pharmaceutical Preparations
- CBFV Major Banks
- Sector
- GLSI Health Care
- CBFV Finance
- Exchange
- GLSI Nasdaq
- CBFV Nasdaq
- Market Cap
- GLSI 133.4M
- CBFV 140.0M
- IPO Year
- GLSI 2020
- CBFV N/A
- Fundamental
- Price
- GLSI $9.39
- CBFV $28.98
- Analyst Decision
- GLSI Strong Buy
- CBFV Hold
- Analyst Count
- GLSI 1
- CBFV 2
- Target Price
- GLSI $39.00
- CBFV $26.00
- AVG Volume (30 Days)
- GLSI 37.8K
- CBFV 43.0K
- Earning Date
- GLSI 08-13-2025
- CBFV 07-23-2025
- Dividend Yield
- GLSI N/A
- CBFV 3.57%
- EPS Growth
- GLSI N/A
- CBFV N/A
- EPS
- GLSI N/A
- CBFV 1.92
- Revenue
- GLSI N/A
- CBFV $49,545,000.00
- Revenue This Year
- GLSI N/A
- CBFV $5.97
- Revenue Next Year
- GLSI N/A
- CBFV $9.49
- P/E Ratio
- GLSI N/A
- CBFV $14.63
- Revenue Growth
- GLSI N/A
- CBFV N/A
- 52 Week Low
- GLSI $8.06
- CBFV $20.99
- 52 Week High
- GLSI $18.15
- CBFV $33.72
- Technical
- Relative Strength Index (RSI)
- GLSI 42.26
- CBFV 54.11
- Support Level
- GLSI $8.67
- CBFV $27.44
- Resistance Level
- GLSI $9.37
- CBFV $28.67
- Average True Range (ATR)
- GLSI 0.28
- CBFV 0.39
- MACD
- GLSI 0.00
- CBFV 0.04
- Stochastic Oscillator
- GLSI 28.74
- CBFV 78.53
About GLSI Greenwich LifeSciences Inc.
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.
About CBFV CB Financial Services Inc.
CB Financial Services Inc operates as a bank holding company. The company conducts its operations through its wholly-owned subsidiary, Community Bank, a Pennsylvania-chartered commercial bank. The Bank offers products and services related to residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a range of deposit products for individuals and businesses in its market area. It operates in two operating units namely Community Banking and Insurance brokerage service segment. The bank generates its revenue in the form of interest.